Papers in peer-reviewed scientific journals.

Transcription

1 2012 Papers in peer-reviewed scientific journals. Amin FM, Asghar MS, Guo S, Hougaard A, Hansen AE, Schytz HW et al. Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers. Cephalalgia. 2012;32(2): Amin FM, Lindberg U, Raghava JM, Hougaard A. Julestemningens cerebrale repræsentation et tværkulturelt, funktionelt magnetisk resonans-studie. Ugeskrift for Laeger. 2012;174(49): Amrutkar DV, Ploug KB, Hay-Schmidt A, Porreca F, Olesen J, Jansen-Olesen I. mrna expression of 5-hydroxytryptamine 1B, 1D, and 1F receptors and their role in controlling the release of calcitonin gene-related peptide in the rat trigeminovascular system. Pain. 2012;153(4): Antonova M, Wienecke T, Olesen J, Ashina M. Prostaglandin (E2) induces immediate migraine-like attack in migraine patients without aura. Cephalalgia. 2012;32(11): Asghar MS, Hansen AE, Larsson HBW, Ashina M, Olesen J. Effect of CGRP and sumatriptan on the BOLD response in visual cortex. Journal of Headache and Pain. 2012; Barløse M, Jennum P, Knudsen S, Jensen RH. Cluster headache and sleep, is there a connection?: A review. Cephalalgia. 2012;32(6): Baun M, Pedersen MHF, Olesen J, Jansen-Olesen I. Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia. 2012;32(4): Bendtsen L, Birk S, Kasch H, Aegidius K, Sørensen PS, Thomsen LL et al. Reference programme: Diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, The Journal of Headache and Pain Online. 2012;13

2 Suppl 1:S1-29. Buse DC, Sollars CM, Steiner TJ, Jensen RH, Al Jumah MA, Lipton RB. Why HURT?: A review of clinical instruments for headache management. Current Pain and Headache Reports. 2012;16(3): Christensen AF, Le H, Kirchmann M, Olesen J. Genotype-phenotype correlation in migraine without aura focusing on the rs variant on 8q22.1. Journal of Headache and Pain. 2012;13(1):21-7. Cooper RJ, Selb J, Gagnon L, Phillip D, Schytz HW, Iversen HK et al. A systematic comparison of motion artifact correction techniques for functional near-infrared spectroscopy. Frontiers in Neuroscience. 2012;6:147. Diener H-C, Dodick DW, Goadsby PJ, Lipton RB, Olesen J, Silberstein SD. Chronic migraine--classification, characteristics and treatment. Nature Reviews. Neurology. 2012;8(3): Egsgaard LL, Buchgreitz L, Wang L, Bendtsen L, Jensen R, Arendt-Nielsen L. Short-term cortical plasticity induced by conditioning pain modulation. Experimental Brain Research. 2012;216(1): Esserlind A-L, Kirchmann M, Hauge AW, Le H, Olesen J. A genotype-phenotype analysis of the 8q22.1 variant in migraine with aura. European Journal of Neurology. 2012;19(4): Jensen RM, Tfelt-Hansen P. Diagnosticerer Lægernes Pensionskasse multipel sklerose korrekt?. Ugeskrift for Laeger. 2012;174(37):2179; discussion Kruuse CR, Gupta S, Nilsson E, Kruse L, Edvinsson L. Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries. European Journal of Pharmacology. 2012;674(2-

3 3): Lampl C, Steiner TJ, Mueller T, Mirvelashvili E, Djibuti M, Kukava M et al. Will (or can) people pay for headache care in a poor country?. Journal of Headache and Pain. 2012;13(1): Le H, Tfelt-Hansen P, Skytthe A, Kyvik KO, Olesen J. Increase in self-reported migraine prevalence in the Danish adult population: a prospective longitudinal population-based study. BMJ Open. 2012;2(4). Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J et al. Vestibular migraine: Diagnostic criteria. Journal of vestibular research : equilibrium & orientation. 2012;22(4): Magis D, Jensen R, Schoenen J. Neurostimulation therapies for primary headache disorders: present and future. Current Opinion in Neurology. 2012;25(3): Mitsikostas DD, Tfelt-Hansen P. Targeting to 5-HT1F Receptor Subtype for Migraine Treatment: Lessons from the Past, Implications for the Future. Central Nervous System Agents in Medicinal Chemistry Munksgaard SB, Bendtsen L, Jensen RH. Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: A comparison of two consecutive treatment methods in an open-label design. Cephalalgia. 2012;32(11): Munksgaard SB, Bendtsen L, Jensen RH. Treatment-resistant medication overuse headache can be cured. Headache Online. 2012;52(7): Myren M, Olesen J, Gupta S. Pharmacological and expression profile of the prostaglandin I(2) receptor in the rat craniovascular system. Vascular Pharmacology. 2012;55(1-3):50-8.

4 Myren M, Olesen J, Gupta S. Prostaglandin E2 receptor expression in the rat trigeminalvascular system and other brain structures involved in pain. Neuroscience Letters. 2012;506(1):64-9. Olesen J. Answer to the letter from Joanna Zakrzewska. Journal of Headache and Pain. 2012;13(2):173. Olesen J. Ten-year anniversary of the European Brain Council: The major achievements. European Journal of Neurology Olesen J, Gustavsson A, Svensson M, Wittchen H-U, Jönsson B, CDBE2010 study group. The economic cost of brain disorders in Europe. European Journal of Neurology. 2012;19(1): Olesen J, Jansen-Olesen I. Towards a reliable animal model of migraine. Cephalalgia. 2012;32(7): Pedersen MHF, Baun M. Tritium labelling of PACAP-38 using a synthetic diiodinated precursor peptide. Journal of Labelled Compounds and Radiopharmaceuticals. 2012;55(1):1-4. Peters M, Perera S, Loder E, Jenkinson C, Gil Gouveia R, Jensen R et al. Quality in the provision of headache care. 1: systematic review of the literature and commentary. The Journal of Headache and Pain Online. 2012;13(6): Peters M, Jenkinson C, Perera S, Loder E, Jensen R, Katsarava Z et al. Quality in the provision of headache care. 2: defining quality and its indicators. The Journal of Headache and Pain Online. 2012;13(6): Phillip D, Schytz HW, Selb J, Payne S, Iversen HK, Skovgaard LT et al. Low frequency oscillations in cephalic vessels assessed by near infrared spectroscopy. European Journal of

5 Clinical Investigation. Supplement Ploug KB, Amrutkar DV, Baun M, Ramachandran R, Iversen A, Lund TM et al. K(ATP) channel openers in the trigeminovascular system. Cephalalgia. 2012;32(1): Ramachandran R, Bhatt DK, Ploug KB, Olesen J, Jansen-Olesen I, Hay-Schmidt A et al. A naturalistic glyceryl trinitrate infusion migraine model in the rat. Cephalalgia. 2012;32(1): Rief W, Kaasa S, Jensen R, Perrot S, Vlaeyen JWS, Treede R-D et al. New proposals for the international classification of diseases-11 revision of pain diagnoses. Journal of Pain. 2012;13(4): Rudkjøbing LA, Esserlind A-L, Olesen J. Future possibilities in migraine genetics. The Journal of Headache and Pain Online. 2012;13(7): Schiffman E, Ohrbach R, List T, Anderson G, Jensen R, John MT et al. Diagnostic criteria for headache attributed to temporomandibular disorders. Cephalalgia. 2012;32(9): Schytz HW, Guo S, Jensen LT, Kamar M, Nini A, Gress DR et al. A New Technology for Detecting Cerebral Blood Flow: A Comparative Study of Ultrasound Tagged NIRS and (133)Xe-SPECT. Neurocritical Care. 2012;17(1): Schytz HW, Wegener M, Lassen LL. Cerebral sinustrombose ved Behçets sygdom. Ugeskrift for Laeger. 2012;174(20): Schytz HW, Hansen JM, Phillip D, Selb J, Boas DA, Ashina M. Nitric Oxide Modulation of Low-Frequency Oscillations in Cortical Vessels in FHM - a NIRS Study. Headache Online

6 Shah AM, Bendtsen L, Zeeberg P, Jensen RH. Reduction of Medication Costs After Detoxification for Medication-Overuse Headache. Headache Online Tfelt-Hansen P, Pascual J, Ramadan N, Dahlöf C, D'Amico D, Diener H-C et al. Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia. 2012;32(1):6-38. Tfelt-Hansen PC, Jensen RH. Management of cluster headache. C N S Drugs. 2012;26(7): Tfelt-Hansen PC, Hougaard A. Migraine: new US guidelines for preventive treatment of migraine. Nature Reviews. Neurology. 2012;8(8): Tfelt-Hansen P, Olesen J. Taking the negative view of current migraine treatments: the unmet needs. C N S Drugs. 2012;26(5): Tfelt-Hansen PC, Olesen J. The 5-HT(1F) receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials. The Journal of Headache and Pain Online. 2012;13(4): Tfelt-Hansen PC, Diener H-C. Why should American headache and migraine patients still be treated with butalbital-containing medicine?. Headache Online. 2012;52(4): Yri HM, Wegener M, Sander B, Jensen R. Idiopathic intracranial hypertension is not benign: a long-term outcome study. Journal of Neurology. 2012;259(5): Yri HM, Jensen RH. Idiopatisk intrakraniel hypertension er en alvorlig tilstand i hastig stigning. Ugeskrift for Laeger. 2012;174(25):